Radiobiological effectiveness and its role in modeling secondary cancer risk for proton therapy.
In proton therapy, a radiobiological effectiveness ratio (RBE) of 1.1 (RBE1.1) is often used. In reality, RBE depends on dose, linear energy transfer (LET), biological end point, and tissue type. Using a value of RBE that may be not accurate may affect dose calculation and hence, outcome.
| Main Authors: | , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Elsevier
2016
|
| _version_ | 1826266726498566144 |
|---|---|
| author | Madkhali, A Timlin, C Partridge, M |
| author_facet | Madkhali, A Timlin, C Partridge, M |
| author_sort | Madkhali, A |
| collection | OXFORD |
| description | In proton therapy, a radiobiological effectiveness ratio (RBE) of 1.1 (RBE1.1) is often used. In reality, RBE depends on dose, linear energy transfer (LET), biological end point, and tissue type. Using a value of RBE that may be not accurate may affect dose calculation and hence, outcome. |
| first_indexed | 2024-03-06T20:43:21Z |
| format | Journal article |
| id | oxford-uuid:34fdfb91-8cf7-493a-89b5-9b59fb12e2bd |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T20:43:21Z |
| publishDate | 2016 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:34fdfb91-8cf7-493a-89b5-9b59fb12e2bd2022-03-26T13:29:30ZRadiobiological effectiveness and its role in modeling secondary cancer risk for proton therapy.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:34fdfb91-8cf7-493a-89b5-9b59fb12e2bdEnglishSymplectic Elements at OxfordElsevier2016Madkhali, ATimlin, CPartridge, MIn proton therapy, a radiobiological effectiveness ratio (RBE) of 1.1 (RBE1.1) is often used. In reality, RBE depends on dose, linear energy transfer (LET), biological end point, and tissue type. Using a value of RBE that may be not accurate may affect dose calculation and hence, outcome. |
| spellingShingle | Madkhali, A Timlin, C Partridge, M Radiobiological effectiveness and its role in modeling secondary cancer risk for proton therapy. |
| title | Radiobiological effectiveness and its role in modeling secondary cancer risk for proton therapy. |
| title_full | Radiobiological effectiveness and its role in modeling secondary cancer risk for proton therapy. |
| title_fullStr | Radiobiological effectiveness and its role in modeling secondary cancer risk for proton therapy. |
| title_full_unstemmed | Radiobiological effectiveness and its role in modeling secondary cancer risk for proton therapy. |
| title_short | Radiobiological effectiveness and its role in modeling secondary cancer risk for proton therapy. |
| title_sort | radiobiological effectiveness and its role in modeling secondary cancer risk for proton therapy |
| work_keys_str_mv | AT madkhalia radiobiologicaleffectivenessanditsroleinmodelingsecondarycancerriskforprotontherapy AT timlinc radiobiologicaleffectivenessanditsroleinmodelingsecondarycancerriskforprotontherapy AT partridgem radiobiologicaleffectivenessanditsroleinmodelingsecondarycancerriskforprotontherapy |